RT Journal Article
SR Electronic
T1 In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-β-dominated adaptive immune response
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.04.20188169
DO 10.1101/2020.09.04.20188169
A1 Ferreira-Gomes, Marta
A1 Kruglov, Andrey
A1 Durek, Pawel
A1 Heinrich, Frederik
A1 Tizian, Caroline
A1 Anne Heinz, Gitta
A1 Pascual-Reguant, Anna
A1 Du, Weijie
A1 Mothes, Ronja
A1 Fan, Chaofan
A1 Frischbutter, Stefan
A1 Habenicht, Katharina
A1 Budzinski, Lisa
A1 Ninnemann, Justus
A1 Jani, Peter K.
A1 Guerra, Gabriela
A1 Lehmann, Katrin
A1 Matz, Mareen
A1 Ostendorf, Lennard
A1 Heiberger, Lukas
A1 Chang, Hyun-Dong
A1 Bauherr, Sandy
A1 Maurer, Marcus
A1 Schönrich, Günther
A1 Raftery, Martin
A1 Kallinich, Tilmann
A1 Alexander Mall, Marcus
A1 Angermair, Stefan
A1 Treskatsch, Sascha
A1 Dörner, Thomas
A1 Max Corman, Victor
A1 Diefenbach, Andreas
A1 Volk, Hans-Dieter
A1 Elezkurtaj, Sefer
A1 Winkler, Thomas H.
A1 Dong, Jun
A1 Erika Hauser, Anja
A1 Radbruch, Helena
A1 Witkowski, Mario
A1 Melchers, Fritz
A1 Radbruch, Andreas
A1 Mashreghi, Mir-Farzin
YR 2020
UL http://medrxiv.org/content/early/2020/09/08/2020.09.04.20188169.abstract
AB Here we have analyzed the dynamics of the adaptive immune response triggered by SARS-CoV-2 in severely affected COVID-19 patients, as reflected by activated B cells egressing into the blood, at the single cell level. Early on, before seroconversion in response to SARS-CoV-2 spike protein, activated peripheral B cells displayed a type 1 interferon-induced gene expression signature. After seroconversion, activated B cells lost this signature, expressed IL-21- and TGF-β-induced gene expression signatures, and mostly IgG1 and IgA1. In the sustained immune reaction of the COVID-19 patients, until day 59, activated peripheral B cells shifted to expression of IgA2, reflecting instruction by TGF-β. Despite the continued generation of activated B cells, those cells were not found in the lungs of deceased COVID-19 patients, nor did the IgA2 bind to dominant antigens of SARS-CoV-2. In severe COVID-19, SARS-CoV-2 thus triggers a chronic immune reaction distracted from itself and instructed by TGF-β.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis Work was supported by the state of Berlin and the European Regional Development Fund to M.F.M. (ERDF 2014 to 2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum), the Berlin Institute of Health with the Starting Grant - Multi-Omics Characterization of SARS-CoV-2 infection, Project 6 Identifying immunological targets in Covid-19 to H.D.V., A.D. and M.F.M., by the Deutsche Forschungsgemeinschaft through the TRR130-P16 and P17 to A.R., H.D.C. and H.R., by the European Research Council through the Advanced Grant IMMEMO (ERC-2010-AdG.20100317 Grant 268978) to A.R., and by the DFG - Projektnummer 389687267 to J.D. and A.R.. A.K. was supported by DFG (TRR241 A04), Russian Science Foundation grant (# 17-74-20059; measurement of serum IgA responses) and Russian fund for basic research (#17-00-00435). A.E.H. was funded by the DFG (TRR130-C01 and P17, HA5354/6-2 and HA5354/8-2). L.B., J.N. and H.D.C. were funded by the Dr. Rolf M. Schwiete Foundation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The recruitment of study subjects was conducted in accordance with the Ethics Committee of the Charite (EA 1/144/13 with EA 1/075/19 and EA 2/066/20) and was in compliance with the Declaration of Helsinki. Four healthy adults (3 male and 1 female; average age 47 +/- 7 (SEM)) and 13 COVID-19 patients (7 male and 6 female; average age 74 +/- 11 (SEM)) with either documented disease history or exposure through natural SARS-CoV-2 infection that were verified by the levels of antigen-reactive antibody IgG titers.Autopsies were performed at the Department of Pathology and Neuropathology, Charite - Universitaetsmedizin Berlin. For sampling postmortem tissue from COVID-19 and control patients, its virological assessment and the histological analysis, the approval from the Ethics Committee of the Charite included EA 1/144/13 with EA 1/075/19 and EA2/066/20 Substudy No.60. The study was in compliance with the Declaration of Helsinki. In all included deceased patients a whole-body autopsy was performed, which included a thorough histopathologic and molecular evaluation comprising virological assessment of SARS-CoV-2 RNA levels as previously described(Corman et al., 2020). Clinical records were assessed for pre-existing medical conditions and medications, current medical course, and ante-mortem diagnostic findings as specified in supplementary Fig. 4a. Cause of death for the control cases was aspiration pneumonia and COVID-19 for the SARS-CoV-2 infected patients.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on request or included in this published article (and its supplementary information files)